Muscular Dystrophy Coordinating Committee Meeting | Muscular Dystrophy Coordinating Committee

Monday, May 09, 2022

Virtual | May 9, 2022, 1-5 pm EDT
View Agenda

Also available on NIH videocast

Meeting Agenda- Muscular Dystrophy Coordinating Committee Meeting - 5/9/2022
Time	Presentation
1:00 – 1:10	Introductions and general information Glen Nuckolls, National Institute of Neurological Disorders and Stroke (NINDS/NIH), MDCC Designated Federal Official
1:10 – 1:40	Chair Presentation Diana Bianchi, Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD/NIH), MDCC Chair
1:40-2:00	Science Advances Supported by the Centers for Disease Control and Prevention (CDC) Natalie Street, CDC
2:00 – 2:45	New Member Presentations Denise Myler, Idaho Caregivers Alliance and the Idaho State Independent Living Council Eric Wang, Myotonic Dystrophy Foundation and Center for Neurogenetics, Univ Florida Chris Anselmo, Muscular Dystrophy Association
2:45-3:00	Break
3:00 – 4:55	“Repurposing Approved Drugs and Previously Deprioritized Compounds” Session Introduction Glen Nuckolls, NINDS/NIH Repurposing of Drugs for the Treatment of Duchenne Muscular Dystrophy Lee Sweeney, University of Florida Drug Repurposing Projects by the NCATS Therapeutics Development Branch Elizabeth Ottinger, National Center for Advancing Translational Sciences (NCATS), NIH Creating Value through Clinical Repurposing Barbara Goodman, Cures Within Reach Repurposing in Muscular Dystrophy: Lessons from FDA/NCATS CURE ID and the CURE Drug Repurposing Collaboratory (CDRC) Heather Stone, Center for Drug Evaluation and Research, U.S. Food & Drug Administration
4:55 - 5:00	Closing Remarks Diana Bianchi, NICHD/NIH
5:00	Adjourn